Home28L • FRA
add
Peptonic Medical AB
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 4.91M | -19.65% |
Operating expense | 8.27M | -43.18% |
Net income | -3.54M | 69.28% |
Net profit margin | -71.98 | 61.77% |
Earnings per share | — | — |
EBITDA | -3.01M | 70.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.67M | 209.17% |
Total assets | 75.79M | -38.56% |
Total liabilities | 24.92M | -34.73% |
Total equity | 50.87M | — |
Shares outstanding | 9.34B | — |
Price to book | 0.02 | — |
Return on assets | -11.40% | — |
Return on capital | -13.62% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.54M | 69.28% |
Cash from operations | -2.49M | -241.37% |
Cash from investing | -235.00K | -147.38% |
Cash from financing | 1.90M | 268.53% |
Net change in cash | -939.00K | 30.91% |
Free cash flow | -1.48M | 94.19% |
About
Founded
2009
Website
Employees
5
